Pfizer, Inc. (NYSE:PFE) is set to announce second quarter earning results on Tuesday 28th July 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, PFE to report 2Q20 income of $ 0.66 per share.
For the full year, analysts anticipate top line of $ 49142.30 million, while looking forward to income of $ 2.88 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 48,500.00 million ~ $ 50,500.00 million, where as bottomline are predicted in a range of $ 2.82 ~ $ 2.92 per share
Click Here For More Historical Outlooks Of Pfizer, Inc.
Previous Quarter Performance
Pfizer, Inc. unfold income for the first quarter of $ 0.80 per share, from the revenue of $ 12,028.00 million. The quarterly earnings lowered 5.88 percent while revenues declined 7.41 percent compared with the same quarter last year.
The consensus estimates are income of $ 0.73 per share from $ 11903.90 million in revenue. The bottom line results beat street analysts by $ 0.07 or 9.59 percent, at the same time, top line results outshined analysts by $ 124.10 million or 1.04 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Pfizer, Inc.
Stock Performance
According to the previous trading day, closing price of PFE was $ 37.54, representing a 34.65 % increase from the 52 week low of $ 27.88 and a 12.7 % decrease over the 52 week high of $ 43.00.
The company has a market capital of $ 208.53 billion and is part of the Healthcare sector and Drug Manufacturers – Major industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”PFE” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Recent Analyst recommendations
- On 1st June 2020, maintained by JPMorgan Chase & Co. at Neutral rating, with $ 36.00 target price.
Recent Stock Dividend Announcement
On June 25, 2020, the board of directors authorized 3Q20 dividend of $ 0.38 per share to holders of record as of the close of business on July 31, 2020, with payment date of September 1, 2020 and ex-dividend date on July 30, 2020.
On April 22, 2020, the board of directors authorized quarterly dividend of $ 0.38 per share to holders of record as of the close of business on May 8, 2020, with payment date of June 5, 2020 and ex-dividend date on May 7, 2020.
Conference Call
Pfizer, Inc. will be hosting a conference call at 10:00 AM eastern time on 28th July 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.pfizer.com
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands.
